​

Drugs Made In America Acquisition Stock (NASDAQ:DMAA)

OwnershipFinancialsChart

Previous Close

$10.70

52W Range

$10.22 - $10.72

50D Avg

$10.64

200D Avg

$10.48

Market Cap

$361.11M

Avg Vol (3M)

$36.46K

Beta

0.00

Div Yield

-

DMAA Company Profile

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Show More

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

Jan 27, 2025

Website

DMAA Performance

DMAA Financial Summary

Dec 25Dec 24
Revenue--
Operating Income-$-479.00
Net Income$3.97M$-479.00
EBITDA--
Basic EPS$0.19$-0.06
Diluted EPS$0.19$-0.06

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
MLACMountain Lake Acquisition Corp.
ALFCenturion Acquisition Corp.
LOKVLive Oak Acquisition Corp. V Class A Ordinary Shares
SIMASIM Acquisition Corp. I
RTACRenatus Tactical Acquisition Corp I Class A Ordinary Shares
TACOBerto Acquisition Corp.
TACHTitan Acquisition Corp.
OYSEOyster Enterprises II Acquisition Corp